AVANSCURE LIFESCIENCES PVT. LTD.
Send Inquiry Send SMS    Call Me Free
We Don't BUY/SELL/MARKET/ consult any products covered under patent or are restricted.
AVANSCURE LIFESCIENCES PVT. LTD. Banner
Tacrolimus Pellets

Tacrolimus Pellets

Product Details:

  • CAS No 104987-11-3
  • Drug Type Medicine Raw Materials
  • Physical Form Powder
  • Click to view more
X

Product Specifications

  • 104987-11-3
  • Powder
  • Medicine Raw Materials

Trade Information

  • Yes
  • Contact us for information regarding our sample policy
  • As per buyer requirements
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • All India, Uttar Pradesh, Andaman and Nicobar Islands, East India, South India, Tamil Nadu, Punjab, Pondicherry, Odisha, Nagaland, Sikkim, Maharashtra, Bihar, Assam, Telangana, Rajasthan, North India, Jharkhand, Daman and Diu, Kerala, Haryana, Uttarakhand, Manipur, Gujarat, Himachal Pradesh, Delhi, Central India, Arunachal Pradesh, Lakshadweep, Andhra Pradesh, Karnataka, , Dadra and Nagar Haveli, Mizoram, Chandigarh, Tripura, Jammu and Kashmir, Madhya Pradesh, Chhattisgarh, Meghalaya, West India, Goa, West Bengal

Product Description

Tacrolimus Pellets

Avanscure Lifesciences Pvt. Ltd., global Manufacturer of Tacrolimus 0.4 , 0.5  offers for your requirements of RND / Development quantities or commercials, based on status of the product.

Preventing organ rejection in certain patients following liver, kidney, or heart transplant. It may be used along with other medicines.

IUPAC NAME :- (1R,9S,12S,13R,14S,17R,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0^{4,9}]octacos-18-ene-2,3,10,16-tetrone

CAS NO. :- 104987-11-3

FORMULA :- C44H69NO12

SYNONYMS :- FK-506;prograf;fr900506;L 679934;Protopic;Advagraf;Fujimycin;TacroBell;TACROLIMUS;FK-506, 99+%

APPLICATION :- For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was first approved by the FDA in 1994 for use in liver transplantation, this has been extended to include kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.

DESCRIPTION :- Tacrolimus (also FK-506 or Fujimycin) is an immunosuppressive drug whose main use is after organ transplant to reduce the activity of the patient immune system and so the risk of organ rejection. It is also used in a topical preparation in the treatment of severe atopic dermatitis, severe refractory uveitis after bone marrow transplants, and the skin condition vitiligo. 

Molar mass 804.018 g/mol




AVANSCURE LIFESCIENCES PVT. LTD.

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.



AVANSCURE LIFESCIENCES PVT. LTD. All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.